Michelle Sholzberg




Dr. Michelle Sholzberg received her MDCM and residency training in Internal Medicine at McGill University and she completed additional postgraduate training in Hematology at the University of Toronto. She has also completed a research hemostasis fellowship in Toronto. Dr. Sholzberg has a Master of Science from the University of Toronto in Clinical Epidemiology and Health Care Research. She is a clinical hematologist with a focus on bleeding and is the Medical Director of the Coagulation Laboratory at St. Michael’s Hospital. She is also the Co-Director of the Hematology-Oncology Clinical Research Group and of the Hematology-Immunology Translational Research Theme. Her research interests include inherited and acquired disorders of hemostasis. Currently, she is involved in the study of: prediction tools for perioperative bleeding, the appropriateness of coagulation testing and new treatments for immune thrombocytopenia.

Recent Publications

  1. Tse, B, Lim, G, Sholzberg, M, Pavenski, K. Describing the point prevalence and characteristics of venous thromboembolism in patients with thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020;18 (11):2870-2877. doi: 10.1111/jth.15027. PubMed PMID:33448602 .
  2. Boccia, R, Cooper, N, Ghanima, W, Boxer, MA, Hill, QA, Sholzberg, M et al.. Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia. Br J Haematol. 2020;190 (6):933-938. doi: 10.1111/bjh.16959. PubMed PMID:33439486 PubMed Central PMC7540289.
  3. Teitel, J, Sholzberg, M. Emergency Management of Hemophilia. J Emerg Med. 2020;59 (4):607-608. doi: 10.1016/j.jemermed.2020.04.063. PubMed PMID:33183681 .
  4. Parker, ML, Storm, S, Sholzberg, M, Yip, PM, Beriault, DR. Revising Ferritin Lower Limits: It's Time to Raise the Bar on Iron Deficiency. J Appl Lab Med. 2020; :. doi: 10.1093/jalm/jfaa152. PubMed PMID:33179023 .
  5. Lee, SG, Fralick, M, Sholzberg, M. CMAJ. 2020;192 (45):E1424. doi: 10.1503/cmaj.200685-f. PubMed PMID:33168770 PubMed Central PMC7669293.
  6. Arya, S, Wilton, P, Page, D, Boma-Fischer, L, Floros, G, Winikoff, R et al.. "Everything was blood when it comes to me": Understanding the lived experiences of women with inherited bleeding disorders. J Thromb Haemost. 2020;18 (12):3211-3221. doi: 10.1111/jth.15102. PubMed PMID:32979008 .
  7. Sholzberg, M. COVID-19 and Hypercoagulability. Clin Adv Hematol Oncol. 2020;18 (7):386-389. . PubMed PMID:32903249 .
  8. Tritschler, T, Mathieu, ME, Skeith, L, Rodger, M, Middeldorp, S, Brighton, T et al.. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020;18 (11):2958-2967. doi: 10.1111/jth.15094. PubMed PMID:32888372 .
  9. Peterson, W, Liederman, Z, Baker, J, Floros, G, Martin, R, Berger, H et al.. Hemorrhagic, thrombotic and obstetric complications of congenital dysfibrinogenemia in a previously asymptomatic woman. Thromb Res. 2020;196 :127-129. doi: 10.1016/j.thromres.2020.08.028. PubMed PMID:32866823 .
  10. Goldberg, N, Nisenbaum, R, Song, H, Lillicrap, D, Teitel, J, James, P et al.. Desmopressin responsiveness by age in type 1 von Willebrand disease. Res Pract Thromb Haemost. 2020;4 (6):1046-1052. doi: 10.1002/rth2.12354. PubMed PMID:32864555 PubMed Central PMC7443436.
Search PubMed

Affiliations & Other Activities

  • Staff Physician, Division of Hematology, St. Michael’s Hospital
  • Assistant Professor, Department of Medicine, University of Toronto